Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
作者： Maria Jure-Kunkel , Francis Y. Lee
DOI:
关键词:
摘要: A method for the treatment of cancer, comprising administration to a mammal in need thereof synergistic, therapeutically effective amount (i) an anti-CTLA-4 antibody, addition one or more diluents, vehicles, excipients, and/or inactive ingredients, and (ii) N (2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)- 1 -piperazinyl]-2-methyl-4pyrimidinyl] amino] -5-thiazolecarboxamide (dasatinib), pharmaceutically acceptable salt, solvate, hydrate thereof, ingredients.
google.co.za 参考文章(82)
Mark Lackner, Veeraswamy Manne, Tak Hung, Mark Maxwell, Rachel Kindt, Katherine Brown, Naomi Laing, Michael Costa, Hai Zhang, Kevin Fitzgerald, Terry Stouch, Louis Lombardo, Mark Lynch, Pamela Carroll, Petra Ross-MacDonald, Jae Lee, Carol O'Brian, Modulators of rabggt and methods of use thereof ,(2003)
Jane A. Gross, Jane A. Gross, James P. Allison, Eleni Callas, Identification and distribution of the costimulatory receptor CD28 in the mouse. Journal of Immunology. ,vol. 149, pp. 380- 388 ,(1992)
Gerhard Hoefle, Soong-Hoon Kim, Nicole Glaser, Thomas Leibold, Gregory Vite, C-21 modified epothilones ,(2000)
Jeffrey Bluestone, Theresa Walunas, Hiromi Fujiwara, Rishani Wijesuriya, Toshiyuki Hamaoka, Shiro Ono, Jie Mu, Yi Fu Yang, Jian Ping Zou, Enhanced Induction of Antitumor T-Cell Responses by Cytotoxic T Lymphocyte-associated Molecule-4 Blockade: The Effect Is Manifested Only at the Restricted Tumor-bearing Stages Cancer Research. ,vol. 57, pp. 4036- 4041 ,(1997)
Steven Fischkoff, Israel Lowy, James Chung-Yin Yang, Michael Yellin, TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy ,(2006)
P. Bretscher, M. Cohn, A Theory of Self- Nonself Discrimination. Science. ,vol. 169, pp. 1042- 1049 ,(1970) , 10.1126/SCIENCE.169.3950.1042
Karin Jooss, Kathryn E. Koprivnikar, Thomas Harding, Minh Nguyen, Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer ,(2008)
Thomas Andrew Davis, Robert F. Graziano, Tibor P. Keler, Alan J. Korman, Methods of treatment using ctla-4 antibodies ,(2003)
Naoya Tsurushita, Clive Wood, Katherine Turner, Denise O'Hara, Donna Morris, Gary Gray, Beatriz Carreno, Paul Hinton, Mary Collins, Antibodies against CTLA4 and uses therefor ,(2005)
Israel Lowy, Geoffrey M. Nichol, Surrogate therapeutic endpoint for anti-ctla-4 based immunotherapy of disease ,(2004)